Clinuvel Pharmaceuticals
CUV.AX
#7544
Rank
C$0.56 B
Marketcap
C$11.19
Share price
-0.51%
Change (1 day)
9.17%
Change (1 year)

Earnings for Clinuvel Pharmaceuticals (CUV.AX)

Earnings in 2025: C$46.42 Million

According to Clinuvel Pharmaceuticals's latest financial reports the company's current earnings are C$62.5 Million. In 2025 the company made an earning of C$46.42 Million, an increase over its 2024 earnings that were of C$46.3 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Clinuvel Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025C$46.42 M0.26%
2024C$46.3 M11.35%
2023C$41.58 M28.31%
2022C$32.41 M22.8%
2021C$26.39 M112.63%
2020C$12.41 M-28.73%
2019C$17.41 M32.79%
2018C$13.11 M75.41%
2017C$7.47 M-332.52%
2016-C$3.22 Million-70.68%
2015-C$10.98 Million53.78%
2014-C$7.14 Million-16.1%
2013-C$8.51 Million-37.92%
2012-C$13.7 Million-18.19%
2011-C$16.75 Million25.31%
2010-C$13.37 Million-21.53%
2009-C$17.03 Million-11.27%
2008-C$19.2 Million80.4%
2007-C$10.64 Million-2.46%
2006-C$10.91 Million-5.35%
2005-C$11.53 Million60.55%
2004-C$7.18 Million97.37%
2003-C$3.64 Million50.62%
2002-C$2.42 Million121.22%
2001-C$1.1 Million254.48%
2000-C$0.31 Million